Literature DB >> 14313500

ALTERATIONS IN MYELIN FATTY ACIDS AND PLASMALOGENS IN MULTIPLE SCLEROSIS.

B GERSTL, M G TAVASTSTJERNA, R B HAYMAN, L F ENG, J K SMITH.   

Abstract

Entities:  

Keywords:  BRAIN CHEMISTRY; CHOLESTEROL; DEMYELINATION; FATTY ACID METABOLISM; LIPID METABOLISM; METABOLISM; MULTIPLE SCLEROSIS; MYELIN SHEATH; PHOSPHOLIPID METABOLISM; PLASMALOGENS

Mesh：

Substances：

Year:  1965        PMID： 14313500     DOI： 10.1111/j.1749-6632.1965.tb20223.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  16 in total

1.  Arachidonic and docosahexanoic acid content of bovine brain myelin: implications for the pathogenesis of multiple sclerosis.

Authors:  K A Ansari; D W Shoeman
Journal:  Neurochem Res       Date:  1990-01       Impact factor: 3.996

2.  Lipid and fatty acid composition is altered in plaque tissue from multiple sclerosis brain compared with normal brain white matter.

Authors:  R Wilson; D R Tocher
Journal:  Lipids       Date:  1991-01       Impact factor: 1.880

3.  [Glycerophosphatides and sphingolipids in normal white matter of multiple sclerosis brains (author's transl)].

Authors:  H Woelk; P Borri
Journal:  Z Neurol       Date:  1973-11-05

4.  The protein composition of myelin in multiple sclerosis (MS) and orthochromatic leukodystrophy (OLD).

Authors:  H H Althaus; H Pilz; D Müller
Journal:  Z Neurol       Date:  1973-11-05

5.  The relationship of biochemical and morphological information in the central nervous system: the problem of sampling.

Authors:  A L Prensky
Journal:  J Am Oil Chem Soc       Date:  1967-12       Impact factor: 1.849

6.  Enzyme activities associated with demyelinating phase of canine distemper. II. Plasmalogenase.

Authors:  D N McMartin; L A Horrocks; A Koestner
Journal:  Acta Neuropathol       Date:  1972       Impact factor: 17.088

7.  Schilder's diffuse sclerosis: a biochemical and ultrastructural study of myelinoclastic demyelinaton.

Authors:  E L Hogan; K C Joseph; J P Hurt; M R Krigman
Journal:  Acta Neuropathol       Date:  1972       Impact factor: 17.088

8.  Plasmalogenase activity in normal and demyelinating tissue of the central nervous system.

Authors:  G B Ansell; S Spanner
Journal:  Biochem J       Date:  1968-06       Impact factor: 3.857

Review 9.  Is the myelin membrane abnormal in multiple sclerosis?

Authors:  D D Wood; M A Moscarello
Journal:  J Membr Biol       Date:  1984       Impact factor: 1.843

10.  Linoleate metabolism in multiple sclerosis.

Authors:  J Belin; N Pettet; A D Smith; R H Thompson; K J Zilkha
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-02       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.